Literature DB >> 20029375

FAAH deficiency promotes energy storage and enhances the motivation for food.

C Touriño1, F Oveisi, J Lockney, D Piomelli, R Maldonado.   

Abstract

RATIONALE: Fatty acid amide hydrolase (FAAH) is the main degrading enzyme of the fatty acid ethanolamides anandamide (AEA) and oleoylethanolamide (OEA), which have opposite effects on food intake and energy balance. AEA, an endogenous ligand of CB(1) cannabinoid receptors, enhances food intake and energy storage, whereas OEA binds to peroxisome proliferator-activated receptors-alpha to reduce food intake and promoting lipolysis. To elucidate the role of FAAH in food intake and energy balance, we have evaluated different metabolic and behavioral responses related to feeding in FAAH-deficient (FAAH(-/-)) mice and their wild-type littermates. METHODOLOGY AND
RESULTS: Total daily food intake was similar in both genotypes, but high-fat food consumption was enhanced during the dark hours and decreased during the light hours in FAAH(-/-) mice. The reinforcing and motivational effects of food were also enhanced in FAAH(-/-) mice as revealed by operant behavioral paradigms. These behavioral responses were reversed by the administration of the selective CB(1) cannabinoid antagonist rimonabant. Furthermore, body weight, total amount of adipose tissue, plasma-free fatty acids and triglyceride content in plasma, liver, skeletal muscle and adipose tissue, were increased in FAAH(-/-) mice. Accordingly, leptin levels were increased and adiponectin levels decreased in these mutants, FAAH(-/-) mice also showed enhanced plasma insulin and blood glucose levels revealing an insulin resistance. As expected, both AEA and OEA levels were increased in hypothalamus, small intestine and liver of FAAH(-/-) mice.
CONCLUSION: These results indicate that the lack of FAAH predominantly promotes energy storage by food intake-independent mechanisms, through the enhancement of AEA levels rather than promoting the anorexic effects of OEA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20029375      PMCID: PMC3709605          DOI: 10.1038/ijo.2009.262

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  39 in total

Review 1.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

3.  Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.

Authors:  Silvana Gaetani; Fariba Oveisi; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

Review 4.  Anandamide amidohydrolase (fatty acid amide hydrolase).

Authors:  N Ueda; S Yamamoto
Journal:  Prostaglandins Other Lipid Mediat       Date:  2000-04       Impact factor: 3.072

5.  Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.

Authors:  A Giuffrida; F Rodriguez de Fonseca; F Nava; P Loubet-Lescoulié; D Piomelli
Journal:  Eur J Pharmacol       Date:  2000-11-17       Impact factor: 4.432

6.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats.

Authors:  N Jamshidi; D A Taylor
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

7.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

8.  The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

Authors:  M Bensaid; M Gary-Bobo; A Esclangon; J P Maffrand; G Le Fur; F Oury-Donat; P Soubrié
Journal:  Mol Pharmacol       Date:  2003-04       Impact factor: 4.436

9.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats.

Authors:  Jin Fu; Janet Kim; Fariba Oveisi; Giuseppe Astarita; Daniele Piomelli
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-23       Impact factor: 3.619

View more
  38 in total

1.  Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats.

Authors:  E K Jones; T C Kirkham
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.

Authors:  Grzegorz Godlewski; Shakiru O Alapafuja; Sándor Bátkai; Spyros P Nikas; Resat Cinar; László Offertáler; Douglas Osei-Hyiaman; Jie Liu; Bani Mukhopadhyay; Judith Harvey-White; Joseph Tam; Karel Pacak; Jacqueline L Blankman; Benjamin F Cravatt; Alexandros Makriyannis; George Kunos
Journal:  Chem Biol       Date:  2010-11-24

3.  Bi-directional modulation of food habit expression by the endocannabinoid system.

Authors:  Carol A Gianessi; Stephanie M Groman; Jane R Taylor
Journal:  Eur J Neurosci       Date:  2019-01-11       Impact factor: 3.386

4.  Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse.

Authors:  Dollada Srisai; Matthew P Gillum; Brandon L Panaro; Xian-Man Zhang; Naiphinich Kotchabhakdi; Gerald I Shulman; Kate L J Ellacott; Roger D Cone
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

5.  N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis.

Authors:  Trisha J Grevengoed; Samuel A J Trammell; Michele K McKinney; Natalia Petersen; Rebecca L Cardone; Jens S Svenningsen; Daisuke Ogasawara; Christina C Nexøe-Larsen; Filip K Knop; Thue W Schwartz; Richard G Kibbey; Benjamin F Cravatt; Matthew P Gillum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-18       Impact factor: 11.205

6.  Genetic interaction of DGAT2 and FAAH in the development of human obesity.

Authors:  Tinglu Ning; Yaoyu Zou; Minglan Yang; Qianqian Lu; Maopei Chen; Wen Liu; Shaoqian Zhao; Yingkai Sun; Juan Shi; Qinyun Ma; Jie Hong; Ruixin Liu; Jiqiu Wang; Guang Ning
Journal:  Endocrine       Date:  2017-02-27       Impact factor: 3.633

Review 7.  Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.

Authors:  José Iglesias; Ludis Morales; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.590

Review 8.  Obesity surgery and gut-brain communication.

Authors:  Hans-Rudolf Berthoud; Andrew C Shin; Huiyuan Zheng
Journal:  Physiol Behav       Date:  2011-02-24

9.  Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.

Authors:  Jie Liu; Resat Cinar; Keming Xiong; Grzegorz Godlewski; Tony Jourdan; Yuhong Lin; James M Ntambi; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

10.  Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism.

Authors:  Whitney H Brown; Matthew P Gillum; Hui-Young Lee; Joao Paulo G Camporez; Xian-man Zhang; Jin Kwon Jeong; Tiago C Alves; Derek M Erion; Blas A Guigni; Mario Kahn; Varman T Samuel; Benjamin F Cravatt; Sabrina Diano; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.